Mochi's bundled model may offer clarity upfront, while Remedy Meds' visit-based approach allows flexibility if patients pause treatment
"Expanding the range of effective treatments is important in helping people sustainably reduce caloric intakes within an increasingly obesogenic environment." A spokesperson for the National Institute for Health and Care Excellence (Nice), which approves drugs for the NHS, said: "Nice can only recommend a medicine for NHS use if a company submits it for appraisal
It is not for human or veterinary consumption, and is not approved for use as a food, drug, cosmetic, or household chemical
doi:10.1186/s12885-021-09164-x
Hussein O, Alkhader A, Gohar A, Bhat A
Drugs that the FDA has identified as presenting "demonstrable difficulties for compounding"